Strategies to help companies grow and profit from bioscience advances will be the focus of a statewide conference July 28-29 at Laramie's Hilton Garden Inn.
The University of Wyoming's Wyoming Technology Business Center (WTBC) will hold the first annual conference of its e2e networking program, "Developing a Technology Business: Bioscience." Conference speakers will offer various strategies early-stage companies can follow in funding their company, developing a product, building a team and planning a successful exit.
The cost for the "Developing a Technology Business: Bioscience" conference is included with e2e membership. For more information about the conference or to RSVP, visit www.uwyo.edu/wtbc or call (307) 766-6395.
The WTBC operates a 30,000-square-foot business incubator at UW. The facility's state-of-the-art data center provides high-speed Internet connectivity for start-up technology companies.
"e2e is designed to improve the climate for the start-up and growth of entrepreneurial companies," says Jon Benson, WTBC chief executive officer. "While the emphasis is on developing a bio-business, the discussions will benefit all types of high growth companies."
The conference starts with a dinner at 5:30 p.m. Thursday, July 28, at the UW Conference Center at the Hilton Garden Inn. Diether Recktenwald, vice president of Advanced Technology with BD Biosciences in San Jose, Calif., will present the evening's keynote address, "How Big Corporate Relationships Can Help the Start-up."
BD Biosciences, a segment of BD, is one of the world's leading manufacturers of medical devices, laboratory equipment and diagnostic products as well as a Fortune 500 company with offices in more than 50 countries.
Friday, July 29, begins with breakfast at 8 a.m. An expert panel of individuals with diverse bio-businesses development experiences will share stories and valuable insights.
Joining Recktenwald on the panel will be:
Larry Fenster, director of ICVRx LLC in Aurora, Colo. and former president of CMI, Global Facility Solutions, and Natkin Energy Management; active angel investor.
Mona Gamboa, president of Happy Jack Software in Laramie and co-founder of three high tech companies.
David Jessen, CTO of Chromatin, Inc. in Chicago and agricultural biotechnology product development expert.
Harry Ross, CEO of DCS Surgical in Boulder, Colo. and former Partner at Aweida Venture Partners.
Two local bio-businesses will be spotlighted: Paul Johnson, CEO of SoftRay and Donald Jarvis, CEO of GlycoBac.
